Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06545656 · ClinicalTrials.gov registry record · Phase 4
Daily Doxycycline to Inform Sexually Transmitted Infection Prophylaxis Regimens
A Phase 4 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 4
- Development phase
- 24
- Enrollment target
NCT06545656 is a Phase 4 study that has completed, run by Emory University. The registered enrollment target is 24 participants.
The verdict
NCT06545656, a Phase 4 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 24 participants
- Enrollment target
Study Summary
The goal of this project is to collect data regarding the concentrations of doxycycline in mucosal tissues after daily dosing for 7 days in people assigned male sex at birth (AMAB) and assigned female sex at birth (AFAB) to inform future studies of doxycycline to protect against bacterial sexually transmitted infections (STIs).
Interventions
- DRUG Doxycycline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2024-09-13 |
| Est. Completion | 2025-04-29 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06545656
The ClinicalTrials.gov registry entry for NCT06545656 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Doxycycline is the first listed.
NCT06545656 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06545656 about?
NCT06545656 is a clinical study titled "Daily Doxycycline to Inform Sexually Transmitted Infection Prophylaxis Regimens". The goal of this project is to collect data regarding the concentrations of doxycycline in mucosal tissues after daily dosing for 7 days in people assigned male sex at birth (AMAB) and assigned female sex at birth (AFAB) to inform future studies of doxycycline to protect against bacterial sexually t...
What is the current status of trial NCT06545656?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 2024-09-13. Estimated completion is 2025-04-29.
What interventions are being tested in trial NCT06545656?
The interventions under investigation include: Doxycycline (DRUG).
Who is sponsoring clinical trial NCT06545656?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.